BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34170022)

  • 1. Benchmarking the centralized urgent plasma exchange service for patients admitted with a diagnosis of suspected acquired thrombotic thrombocytopenic purpura at a large healthcare system.
    Seheult JN; Stram MN; Sevcik J; Kaplan A; Kiss JE
    J Clin Apher; 2021 Oct; 36(5):678-686. PubMed ID: 34170022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutical plasma exchange for thrombotic thrombocytopenic purpura in the emergency department: A single center experience.
    Li XM; Mo XY; Huang GQ; Zhang FJ
    Am J Emerg Med; 2021 Aug; 46():556-559. PubMed ID: 33214018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In patients with suspected immune TTP, admission source impacts hospital length of stay and time to therapeutic plasma exchange impacts clinical outcomes.
    Soares Ferreira Junior A; Pinheiro Maux Lessa M; Boyle SH; Sanborn K; Kuchibhatla M; Onwuemene OA
    Thromb Res; 2023 Jul; 227():34-39. PubMed ID: 37210956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Altuntas F; Aydogdu I; Kabukcu S; Kocyigit I; Cikim K; Sari I; Erkut MA; Eser B; Ozturk A; Kaya E; Cetin M; Keskin A; Unal A
    Transfus Apher Sci; 2007 Feb; 36(1):57-67. PubMed ID: 17240195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
    Soucemarianadin M; Benhamou Y; Delmas Y; Pichereau C; Maury E; Pène F; Halimi JM; Presne C; Thouret JM; Veyradier A; Coppo P
    Eur J Haematol; 2016 Aug; 97(2):183-91. PubMed ID: 26608617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
    Mehmood T; Taylor M; Winters JL
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of lymphoplasmapheresis compared with therapeutic plasma exchange for thrombotic thrombocytopenic purpura: a retrospective evaluation.
    Zhang Z; Yuan X; Jiang Y; Li N; Li B
    Hematology; 2022 Dec; 27(1):167-172. PubMed ID: 35068383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry.
    Radhwi O; Badawi MA; Almarzouki A; Al-Ayoubi F; ElGohary G; Asfina KN; Basendwah AM; Alhazmi IA; Almahasnah EA; AlBahrani A; Raizah AA; Yahya A; Alshahrani K; Hindawi S
    J Clin Apher; 2023 Oct; 38(5):573-581. PubMed ID: 37317696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How we approach an acquired thrombotic thrombocytopenic purpura patient.
    Raval JS; Mazepa MA; Brecher ME; Park YA
    Transfusion; 2014 Oct; 54(10):2375-82. PubMed ID: 25070750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acquired Thrombotic Thrombocytopenic Purpura in the U.S. remains heterogeneous: Current and future points of clinical equipoise.
    Mazepa MA; Raval JS; Brecher ME; Park YA
    J Clin Apher; 2018 Jun; 33(3):291-296. PubMed ID: 29150875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Venous thrombo-embolism during immune-mediated thrombotic thrombocytopenic purpura is prevalent in patients with a prolonged treatment with therapeutic plasma exchange].
    Benhamou Y; Sauvètre G; Grangé S; Veyradier A; Coppo P
    Rev Med Interne; 2020 Dec; 41(12):809-813. PubMed ID: 32727695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of albumin and compounded plasma for plasma exchange in acquired thrombotic thrombocytopenic purpura.
    Hou R; Tian W; Qiao R; Zhang J
    J Clin Apher; 2020 Jun; 35(3):154-162. PubMed ID: 32110837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.
    O'Brien KL; Price TH; Howell C; Delaney M
    J Clin Apher; 2013 Dec; 28(6):416-21. PubMed ID: 23857424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange.
    Peedin AR; Park YA; Mazepa MA; Rollins-Raval MA; Brecher ME; Raval JS
    Ther Apher Dial; 2018 Dec; 22(6):662-665. PubMed ID: 30178615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpura.
    Liu C; Kallogjeri D; Dynis M; Grossman BJ
    Transfusion; 2013 May; 53(5):1096-107. PubMed ID: 22905833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Fresh Frozen Plasma and Cryosupernatant Plasma for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Institution Experience.
    Lin Q; Fan L; Huang H; Zeng F; Fu D; Wei S
    Biomed Res Int; 2019; 2019():1756109. PubMed ID: 30834255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange for thrombotic thrombocytopenic purpura with refractory thrombocytopenia.
    Maloney N; Martin I; Szczepiorkowski ZM; Dunbar NM
    J Clin Apher; 2018 Jun; 33(3):436-438. PubMed ID: 29270999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution.
    Logothetis CN; Patel A; Eatrides J; Jaglal M; Haider M; Visweshwar N; Laber DA
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic plasma exchange in patients with grade 2-3 hematopoietic stem cell transplantation-associated thrombotic thrombocytopenic purpura: a ten-year experience.
    Christidou F; Athanasiadou A; Kalogiannidis P; Natse T; Bamichas G; Salum R; Sakellari I; Anagnostopoulos A; Fassas A; Sombolos K
    Ther Apher Dial; 2003 Apr; 7(2):259-62. PubMed ID: 12918953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.